Follow
Matthew Watson
Matthew Watson
Bioeconomy Policy Analyst, MITRE
Verified email at mitre.org
Title
Cited by
Cited by
Year
Absorbing citywide patient surge during Hurricane Sandy: a case study in accommodating multiple hospital evacuations
AA Adalja, M Watson, N Bouri, K Minton, RC Morhard, ES Toner
Annals of emergency medicine 64 (1), 66-73. e1, 2014
1012014
Global catastrophic biological risks: toward a working definition
M Schoch-Spana, A Cicero, A Adalja, G Gronvall, T Kirk Sell, D Meyer, ...
Health security 15 (4), 323-328, 2017
822017
Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations
KJ Rambhia, M Watson, TK Sell, R Waldhorn, E Toner
Biosecurity and bioterrorism: biodefense strategy, practice, and science 8 …, 2010
782010
Interim framework for COVID-19 vaccine allocation and distribution in the United States
E Toner, A Barnill, C Krubiner, J Bernstein, L Privor-Dumm, M Watson, ...
Baltimore: Johns Hopkins Center for Health Security, 2020
492020
Characteristics of microbes most likely to cause pandemics and global catastrophes
AA Adalja, M Watson, ES Toner, A Cicero, TV Inglesby
Global catastrophic biological risks, 1-20, 2019
492019
Public health preparedness funding: key programs and trends from 2001 to 2017
CR Watson, M Watson, TK Sell
American journal of public health 107 (S2), S165-S167, 2017
462017
Federal agency biodefense funding, FY2013-FY2014
TK Sell, M Watson
Biosecurity and bioterrorism: Biodefense strategy, practice, and science 11 …, 2013
452013
A community checklist for health sector resilience informed by Hurricane Sandy
ES Toner, M McGinty, M Schoch-Spana, DA Rose, M Watson, E Echols, ...
Health security 15 (1), 53-69, 2017
352017
Assessing the bioweapons threat
C Boddie, M Watson, G Ackerman, GK Gronvall
Science 349 (6250), 792-793, 2015
342015
Enabling emergency mass vaccination: innovations in manufacturing and administration during a pandemic
D Hosangadi, KL Warmbrod, EK Martin, A Adalja, A Cicero, T Inglesby, ...
Vaccine 38 (26), 4167-4169, 2020
332020
The characteristics of pandemic pathogens
AA Adalja, M Watson, ES Toner, A Cicero, TV Inglesby
Johns Hopkins Center for Health Security: Baltimore, MD, USA, 28, 2018
312018
Federal funding for health security in FY2016
C Boddie, TK Sell, M Watson
Health security 13 (3), 186-206, 2015
252015
Building the global vaccine manufacturing capacity needed to respond to pandemics
TK Sell, D Gastfriend, M Watson, C Watson, L Richardson, A Cicero, ...
Vaccine 39 (12), 1667, 2021
202021
A conceptual approach to improving care in pandemics and beyond: severe lung injury centers
AA Adalja, M Watson, RE Waldhorn, ES Toner
Journal of Critical Care 28 (3), 318. e9-318. e15, 2013
202013
Federal funding for health security in FY2015
C Boddie, TK Sell, M Watson
Biosecurity and bioterrorism: biodefense strategy, practice, and science 12 …, 2014
172014
Federal funding for health security in FY2019
C Watson, M Watson, D Gastfriend, TK Sell
Health security 16 (5), 281-303, 2018
162018
Clade X: a pandemic exercise
C Watson, ES Toner, MP Shearer, C Rivers, D Meyer, C Hurtado, ...
Health security 17 (5), 410-417, 2019
142019
Vaccine platforms: state of the field and looming challenges
AA Adalja, M Watson, A Cicero, T Inglesby
CHS: Johns Hopkins Center for Health Security, 2019
142019
Expert views on biological threat characterization for the US Government: a Delphi study
CR Watson, MC Watson, G Ackerman, GK Gronvall
Risk Analysis 37 (12), 2389-2404, 2017
142017
Federal funding for health security in FY2017
C Boddie, M Watson, TK Sell
Health security 14 (5), 284-304, 2016
142016
The system can't perform the operation now. Try again later.
Articles 1–20